Catching Up with the Rare Daily: Genetic Disorders UK, Pediatric Palliative Care & Congres
December 19, 2014
Related
FDA approves Pharming’s Joenja for the treatment of APDS
Rare Daily Staff The U.S. Food and Drug Administration has approved Pharming Group’s Joenja for the treatment […]
Read moreNHS Patients with rare genetic disorders to be fast-tracked to earlier diagnosis and specialist care
Rare Daily Staff NHS England said it is launching a new service to fast track diagnosis and […]
Read moreEuropean Commission Approves Amicus’ Pombiliti in Patients with Late-Onset Pompe Disease
Rare Daily Staff The European Commission has granted approval for Amicus Therapeutics’ Pombiliti, a long-term enzyme replacement […]
Read moreIonis and AstraZeneca Report Positive Topline 66-Week Results of Eplontersen Phase 3 Study for Patients with ATTRv-PN
Rare Daily Staff Ionis Pharmaceuticals and AstraZeneca reported positive topline results from the 66-week analysis of the […]
Read moreNICE Recommends PTC’s AADC Gene Therapy
Rare Daily Staff The United Kingdom’s National Institute for Health and Care Excellence, the drug price watchdog, […]
Read morePTC and Innozyme CEOs Each Announce Their Retirement
Rare Daily Staff PTC Therapeutics Founding CEO Stuart Peltz said that he is stepping down after 25 […]
Read more2023 RARE Mental Health Grant Recipients Announced
Global Genes is pleased to announce the Rare Disease Patient Advocacy Organizations receiving 2023 RARE Mental Health […]
Read moreSeeking a Sustainable Business Developing on N-of-1 Therapies
The ability to pinpoint the underlying genetic causes of diseases and rapidly generate genetic medicines to address […]
Read moreGlobal Genes Team Shares Their Stories on World Rare Disease Day
My daughter Juno was diagnosed with a very rare, severe neurodevelopmental condition called STXBP1-related disorder six years […]
Read more